Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES Academic Article uri icon

Overview

MeSH Major

  • Carcinoma, Hepatocellular
  • Hepatitis C, Chronic
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Liver Cirrhosis
  • Liver Neoplasms

abstract

  • In patients with chronic HCV, statin use was associated with a dose-dependent reduction in incident cirrhosis and HCC. Atorvastatin and fluvastatin were associated with the most significant antifibrotic effects, compared with other statins. (Hepatology 2016;64:47-57).

publication date

  • July 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4917438

Digital Object Identifier (DOI)

  • 10.1002/hep.28506

PubMed ID

  • 26891205

Additional Document Info

start page

  • 47

end page

  • 57

volume

  • 64

number

  • 1